IP Library Granted Patent US 9,782,245
Granted Patent B2
US 9,782,245 · App. 14/008,170 · Granted Oct 10, 2017

Implants, tools, and methods for treatment of pelvic conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,782,245
App. No.
14/008,170
Granted
Oct 10, 2017
Kind
B2
Abstract

Described are various embodiments of surgical procedures, systems, implants, devices, tools, and methods, useful for treating pelvic conditions in a male or female, the pelvic conditions including incontinence (various forms such as fecal incontinence, stress urinary incontinence, urge incontinence, mixed incontinence, etc.), vaginal prolapse (including various forms such as enterocele, cystocele, rectocele, apical or vault prolapse, uterine descent, etc.), and other conditions caused by muscle and ligament weakness, the devices and tools including devices and tools for anchoring an implant to supportive tissue and adjusting the implant.

Claims (47)

1. A pelvic implant useful to treat a pelvic condition, the implant comprising:

a tissue support portion piece, a first extension portion piece, and a second extension portion piece,

a first adjusting mechanism comprising an elongate first flexible strip having a length, a width, and a thickness, the length being greater than the width, and the width being greater than the thickness, the first flexible strip comprising first edge and second edge opposite the first edge extending in the length and thickness directions and a first surface and an opposed second surface extending in the length and width dimensions between the opposed edges, the first flexible strip forming a first flexible strip loop connecting the first extension portion piece and a first end of the tissue support portion piece, wherein the first flexible strip loop is configured to be tightened to reduce a distance between the first extension portion piece and the tissue support portion piece,

a second adjusting mechanism comprising a second flexible strip having a length, a width, and a thickness, the length being greater than the width, and the width being greater than the thickness, the second flexible strip comprising a first edge and a second edge opposite the first edge extending in the length and thickness directions and a first surface and an opposed second surface extending in the length and width dimensions between the opposed edges, the second flexible strip forming a second flexible strip loop connecting the second extension portion piece and a second end of the tissue support portion piece, wherein the second flexible strip loop is configured to be tightened to reduce a distance between the second extension portion piece and the tissue support portion piece,

a self-fixating tip at a distal end of the first extension portion piece, and

a self-fixating tip at a distal end of the second extension portion piece.

2. The implant as recited at claim 1 , wherein

the tissue support portion piece comprises a first end comprising a first aperture and a second end comprising a second aperture,

the first extension portion piece comprises an aperture at a proximal end, and the second extension portion piece comprises an aperture at a proximal end.

3. The implant as recited at claim 2 , wherein

an end of the first flexible strip is secured to the first end of the tissue support portion piece,

the first flexible strip loop extends from the first end of the tissue support portion piece and passes through the aperture at the proximal end of the first extension portion piece, from where the first flexible strip loop then extends to and passes through the aperture at the first end of the tissue support portion piece,

the first flexible strip extends away from the aperture at the first end of the tissue support portion piece as a loose end that can be pulled to tighten the first flexible strip loop to reduce a distance between the first extension portion piece and the tissue support portion piece.

4. The implant as recited at claim 3 comprising supportive portions consisting of a central support portion and two extension portions.

5. The implant as recited at claim 2 , wherein

an end of the first flexible strip is secured to the proximal end of the first extension portion piece,

the first flexible strip loop extends from the proximal end of the first extension portion piece and passes through the aperture at the first end of the tissue support portion piece, from where the first flexible strip loop then extends to and passes through the aperture at the proximal end of the first extension portion piece,

the first flexible strip extends away from the aperture at the proximal end of the first extension portion piece as a loose end that can be pulled to tighten the first flexible strip loop to reduce a distance between the first extension portion piece and the tissue support portion piece.

6. The implant as recited at claim 5 comprising supportive portions consisting of a central support portion and two extension portions.

7. The implant as recited at claim 5 comprising frictional features located on one of the first or the opposed second surfaces of the first and the second flexible strips.

8. The implant as recited at claim 7 , wherein the frictional feature includes teeth, ridges, extensions, bumps, lumps, bulges, protrusion, detents, or springs.

9. The implant as recited at claim 1 , wherein the implant has a length to allow the self-fixating tips to be placed at tissue of opposing obturator foramen of a patient, with the tissue support portion supporting tissue of a urethra or anus.

10. The implant as recited at claim 1 , wherein the first flexible strip comprises frictional features extending from one of the first and opposed second surfaces.

11. The implant as recited at claim 10 , wherein frictional features are formed by making a cut in the first flexible strip, wherein the frictional features lie flat when the flexible strip lies flat, and the frictional features extend from the one of the first and opposed second surfaces of the flexible strip when the flexible strip bends.

12. The implant as recited at claim 11 , wherein, when the first flexible strip passes through one of the apertures by bending, the frictional features extend from the one of the first and opposed second surfaces of the first flexible strip and engage a surface of the aperture, preventing movement of the first flexible strip in a manner that would increase the size of the first flexible strip loop.

13. The implant as recited at claim 11 , wherein, with the first flexible strip under tension, the frictional feature prevents movement of the first flexible strip in a manner that would increase the size of the first flexible strip loop.

14. The implant as recited at claim 10 , wherein the frictional feature is selected from: teeth, ridges, extensions, bumps, lumps, bulges, protrusion, detents, or springs.

15. The implant as recited at claim 1 , wherein, with the implant placed within a patient with the self-fixating tips at tissue of opposing obturator foramen and the central support portion supporting tissue of a urethra or anus, a proximal end of the first flexible strip is capable of being accessed through a medial incision of the patient to actuate the first adjusting mechanism.

16. A method of treating a pelvic condition, the method comprising providing an implant as recited at claim 1 ,

placing the implant in a patient to support pelvic tissue,

actuating the first adjusting mechanism to reduce a size of the first flexible strip loop.

17. The method as recited at claim 16 comprising actuating the second adjusting mechanism to reduce a size of the second flexible strip loop.

18. The method as recited at claim 16 , wherein the pelvic condition is selected from the group consisting of: fecal incontinence and urinary incontinence.

19. The method as recited at claim 16 for treating urinary incontinence, the method comprising:

creating a medial incision in the patient,

placing the tissue support portion piece to contact tissue to support a urethra,

placing the distal end of the first extension portion piece in a tissue path extending toward a first obturator foramen of the patient, and

placing the distal end of the second extension portion piece in a tissue path extending toward a second obturator foramen of the patient.

20. The implant as recited at claim 1 , wherein the first flexible strip is not a suture and the second flexible strip is not a suture.

21. The implant as recited at claim 1 , wherein the first flexible strip has a rectangular cross section when viewed along the length.

22. A pelvic implant useful to treat a pelvic condition, the implant comprising:

a tissue support portion piece, a first extension portion piece, and a second extension portion piece,

a first adjusting mechanism comprising an elongate first flexible strip having a length, a width, and a thickness, the length being greater than the width, and the width being greater than the thickness, the first flexible strip comprising a first edge and a second edge opposite the first edge extending in the length and thickness directions and a first surface, an opposed second surface extending in the length and width dimensions between the opposed edges, the first flexible strip forming a first flexible strip loop connecting the first extension portion piece and a first end of the tissue support portion piece, and frictional features extending from one of the first and opposed second surfaces, wherein the first flexible strip loop is configured to be tightened to reduce a distance between the first extension portion piece and the tissue support portion piece,

a second adjusting mechanism comprising a second flexible strip having a length, a width, and a thickness, the length being greater than the width, and the width being greater than the thickness, the second flexible strip comprising a first edge and a second edge opposite the first edge extending in the length and thickness directions and a first surface and an opposed second surface extending in the length and width dimensions between the opposed edges, the second flexible strip forming a second flexible strip loop connecting the second extension portion piece and a second end of the tissue support portion piece, wherein the second flexible strip loop is configured to be tightened to reduce a distance between the second extension portion piece and the tissue support portion piece,

wherein, when the first flexible strip passes through an aperture of the tissue support portion piece, with the first flexible strip under tension, the frictional features extend from one of the first and opposed second surfaces and engage a surface of the aperture, preventing movement of the first flexible strip in a manner that increases the size of the first flexible strip loop,

a self-fixating tip at a distal end of the first extension portion piece, and

a self-fixating tip at a distal end of the second extension portion piece.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043777/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043778/0167 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2013
From: MUJWID, JAMES R.; TITUS, JOHN E.
To: AMS RESEARCH CORPORATION
Reel/Frame 031679/0924 →